Treatment Options

Learn about the latest treatments for advanced cancer. We’ve got it covered, from new FDA approvals to emerging approaches in immunotherapy, targeted therapy, cancer vaccines, modified viruses, and more.

Clinical Challenges: Platinum-Resistant Ovarian Cancer

George Lundberg, MD | August 7, 2020
Research Areas: Ovarian Cancer

FDA Approves Merck’s Keytruda, Foundation Medicine CDx for TMB-High Solid Tumors

George Lundberg, MD | August 7, 2020
Research Areas: Bladder Cancer, Breast Cancer, Colorectal Cancer, Esophageal Cancer, Kidney Cancer, Liver Cancer, Lung Cancer, Melanoma, Ovarian Cancer, Pancreatic Cancer, Prostate Cancer, Uterine Cancer

Expert on Emergence of Osimertinib, New Discoveries in Lung Cancer Care

George Lundberg, MD | August 7, 2020
Research Areas: Lung Cancer

FDA Grants Rare Pediatric Disease Designation to ONC201 for the Treatment of H3 K27M-Mutant Glioma

Erika Vial Monteverdi | August 4, 2020
Research Areas: Brain Cancer, Diffuse Midline Glioma (DMG/DIPG)

Diffuse Midline Gliomas

George Lundberg, MD | July 11, 2020
Research Areas: Diffuse Midline Glioma (DMG/DIPG)

New Treatments for Ovarian Cancer in 2020

Smruti Vidwans, PhD | June 8, 2020
Research Areas: Ovarian Cancer

China NMPA Approves Optune for the Treatment of Newly Diagnosed and Recurrent Glioblastoma

George Lundberg, MD | May 30, 2020
Research Areas: Brain Cancer

Overall Survival Benefit Shown for Maintenance Olaparib in Ovarian Cancer

George Lundberg, MD | May 30, 2020
Research Areas: Ovarian Cancer

FDA Approves Frontline Atezolizumab for PD-L1–High NSCLC

George Lundberg, MD | May 30, 2020
Research Areas: Lung Cancer

No OS Boost With Opdivo in Recurrent Glioblastoma

George Lundberg, MD | May 30, 2020
Research Areas: Brain Cancer